Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human CKM Protein, N-His

Catalog #:   YHC21101 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P06732
Protein length: Met1-Lys381
Overview

Catalog No.

YHC21101

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met1-Lys381

Predicted molecular weight

45.41 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P06732

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Creatine kinase M chain, Creatine phosphokinase M-type, Creatine kinase M-type, CKMM, CKM, CPK-M, M-CK

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CKM
References

Contrasting Becker and Duchenne muscular dystrophy serum biomarker candidates by using data independent acquisition LC-MS/MS., PMID:40483507

Oxaloacetate and Ketone Bodies Synergistically Promote Myoblast Differentiation in L6 Cells., PMID:40430274

Restoration of branched chain amino acid catabolism improves kidney function in preclinical cardiovascular-kidney-metabolic syndrome models., PMID:40409667

Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study., PMID:40405968

Association of Three Composite Inflammatory and Lipid Metabolism Indicators With Cardiovascular-Kidney-Metabolic Syndrome: A Cross-Sectional Study Based on NHANES 1999-2020., PMID:40376312

Rationale and design of a randomised phase II multicentre crossover trial investigating a sodium-glucose co-transporter 2 inhibitor, dapagliflozin, combined with a novel continuous ketone monitor in adults with type 1 diabetes to reduce the risk of diabetic ketoacidosis: the PARTNER study., PMID:40328646

Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome., PMID:40287685

Influence of Genetic Polymorphisms and Biochemical Biomarkers on Response to Nutritional Iron Supplementation and Performance in a Professional Football Team: A Pilot Longitudinal Study., PMID:40284242

Genetic Profiling and Performance Optimization in Elite Combat Sport Athletes: A Cross-Sectional Study Based on Total Genetic Score Analysis., PMID:40282421

Adherence to a Healthy Plant-Based Diet and Cardiovascular-Kidney-Metabolic Risk Factors in Patients with Moderate to Advanced Chronic Kidney Disease., PMID:40277953

hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients., PMID:40276550

Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation., PMID:40203836

On the front lines of cardiovascular-kidney-metabolic syndrome: Review of GLP-1 and Dual GLP-1/GIP receptor agonists in CV and kidney health., PMID:40197714

The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies., PMID:40128747

Ultra-processed foods and cardio-kidney-metabolic syndrome: A review of recent evidence., PMID:40122730

The effects of volitional hyperpnea on biomarkers of respiratory muscle damage in healthy young men., PMID:40110901

Association of cardiovascular-kidney-metabolic health and apolipoprotein E4 genotype with risk of dementia and mortality., PMID:40095665

LAMP2-FLOT2 interaction enhances autophagosome-lysosome fusion to protect the septic heart in response to ILC2., PMID:40066518

Dialysis in the Elderly: A Practical Guide for the Clinician., PMID:40034192

Finding Potential Drug Targets for Pre-Eclampsia Using Mendelian Randomisation and Colocalisation Analysis., PMID:40028697

A Protocol to Purify Human Mediator Complex From Freestyle 293-F Cells., PMID:40028032

A Hypothesis That Glucagon-like Peptide-1 Receptor Agonists Exert Immediate and Multifaceted Effects by Activating Adenosine Monophosphate-Activate Protein Kinase (AMPK)., PMID:40003662

Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study., PMID:39968297

Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders., PMID:39931238

Elucidating the mechanism of phthalates induced osteoporosis through network toxicology and molecular docking., PMID:39884015

Limiting cap-dependent translation increases 20S proteasomal degradation and protects the proteomic integrity in autophagy-deficient skeletal muscle., PMID:39878121

Cardiac ATP production and contractility are favorably regulated by short-term S100A9 blockade after myocardial infarction., PMID:39870300

Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study., PMID:39856691

Effect of gestational age and fetal sex on metabolism of creatine by uteri, placentae, and fetuses of pigs†., PMID:39836382

Molecular and Functional Significance of Growth Differentiation Factor-15: A Review on Cardiovascular-Kidney-Metabolic Biomarker., PMID:39781722

Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma., PMID:39778168

Genotypic Influences on Actuators of Aerobic Performance in Tactical Athletes., PMID:39766802

An overview of cardiovascular-kidney-metabolic syndrome., PMID:39705194

Association of serum Klotho with the severity and mortality among adults with cardiovascular-kidney-metabolic syndrome., PMID:39695774

The CDK8 kinase module: A novel player in the transcription of translation initiation and ribosomal genes., PMID:39565680

Systemic chemokine-modulatory regimen combined with neoadjuvant chemotherapy in patients with triple-negative breast cancer., PMID:39542655

Distinct effects of CDK8 module subunits on cellular growth and proliferation in Drosophila., PMID:39531377

Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci., PMID:39398225

The effects of inspiratory muscle training on biomarkers of muscle damage in recovered COVID-19 patients after weaning from mechanical ventilation., PMID:39365635

Structural basis of the human transcriptional Mediator regulated by its dissociable kinase module., PMID:39321804

Med13 is required for efficient P-body recruitment and autophagic degradation of Edc3 following nitrogen starvation., PMID:39320938

Cardiac function and energetics in mice with combined genetic augmentation of creatine and creatine kinase activity., PMID:39276853

Cardiac Troponin to Adjudicate Subclinical Heart Failure in Diabetic Patients and a Murine Model of Metabolic Syndrome., PMID:39225064

Exploring the Biomarkers and Potential Mechanisms of Botulinum Toxin Type A in the Treatment of Microglial Inflammatory Activation through P2X7 Receptors based on Transcriptome Sequencing., PMID:39177140

Plasma proteomics implicate glutamic oxaloacetic transaminases as potential markers for acute myocardial infarction., PMID:39173902

The Association of Genetic Markers Involved in Muscle Performance Responding to Lactate Levels during Physical Exercise Therapy by Nordic Walking in Patients with Long COVID Syndrome: A Nonrandomized Controlled Pilot Study., PMID:39125881

Association of Genetic Profile with Muscle Mass Gain and Muscle Injury Prevention in Professional Football Players after Creatine Supplementation., PMID:39125391

Structures and compositional dynamics of Mediator in transcription regulation., PMID:39067114

Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder., PMID:39060163

Docosahexaenoic acid supplementation during porcine oocyte in vitro maturation improves oocyte quality and embryonic development by enhancing the homeostasis of energy metabolism., PMID:39013287

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CKM Protein, N-His [YHC21101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only